Endometrial cancer is the most common gynecological cancer in the developed world, and it
is one of the few cancer types that is becoming more prevalent and leading to more deaths …

The objectives of this Clinical Expert Series on endometrial hyperplasia are to review the
etiology and risk factors, histologic classification and subtypes, malignant progression risks …

Adenocarcinoma of the endometrium (also known as endometrial cancer, or more broadly
as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the …

Endometrial carcinoma is a malignant epithelial tumor that forms in the inner lining, or
endometrium, of the uterus. Endometrial carcinoma is the most common gynecologic …

Background To inform treatment decisions in women diagnosed with endometrial
hyperplasia, quantification of the potential for concurrent endometrial cancer and the future …

Simple Summary Endometrial cancer has a high epidemiological impact, and its
management is part of everyday clinical practice. International guidelines have been …

Simple Summary There are currently no blood biomarkers approved for routine clinical use
in endometrial cancer. Serum human epididymis protein 4 (HE4) is significantly higher in …

This review article explores the possibility of develo** an integrated approach to the
management of the different needs of endometrial cancer (EC) patients seeking to become …

Abstract Purpose Intrauterine levonorgestrel (LNG-IUD) is used to treat patients with
endometrial adenocarcinoma (EAC) and endometrial hyperplasia with atypia (EHA) but …

Abstract Study Objective To evaluate safety and effectiveness of the combination of
hysteroscopic endometrial focal resection with levonorgestrel-releasing intrauterine device …